Schering-Plough Corporation (NYSE: SGP) announced that it has entered into an agreement with Merck & Co., Inc. to commence development of an ezetimibe and atorvastatin combination product.
Severe heart attacks are often treated with non-surgical procedures that open narrowed or blocked arteries of the heart using stents (percutaneous coronary intervention, or PCI).
High-risk surgical patients in community hospital settings can safely benefit from the use of new embolus-removing and stent-inserting systems, according to a study presented today at the American College of Cardiology?s Innovation in Intervention: i2 Summit in New Orleans, La.
High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.
In patients undergoing cardiac catheterization, contrast dye injection can sometimes cause contrast-induced nephropathy (CIN), otherwise known as acute renal failure.
Using the massive computer-simulation power of the San Diego Supercomputer Center (SDSC) at UC San Diego, researchers are zeroing in on the causes of Parkinson’s disease, Alzheimer’s disease, rheumatoid arthritis and other diseases.
Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications.
Genetics and family history play a large role in a person?s risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease.
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions and controversy surrounding the safety and efficacy of drug-eluting stents continue to dominate discussions and headlines.
Healthcare experts will discuss the challenges and opportunities of RFID technology in health care and its implications on government policy during the first IEEE International RFID Conference (IEEE RFID 2007).